Difference between revisions of "Covid: treatments"
| Line 1: | Line 1: | ||
| + | |||
| + | |||
| + | ==General== | ||
*[https://aapsonline.org/CovidPatientTreatmentGuide.pdf "A Guide to Home-Based Covid Treatment,"] from a reputable source, a pdf book. | *[https://aapsonline.org/CovidPatientTreatmentGuide.pdf "A Guide to Home-Based Covid Treatment,"] from a reputable source, a pdf book. | ||
| − | [https://sebastianrushworth.com/2021/05/09/update-on-ivermectin-for-covid-19/ "Update on ivermectin for covid-19,"] Sebastian Rushworth (April 2021). | + | ---- |
| + | |||
| + | ==FDA Murders== | ||
| + | *[https://twitter.com/ESYudkowsky/status/1462960741049200643 Eliezer Yudkowsky tweet], November 2021. He also cites a good Astralcodex10 post on the situation. | ||
| + | {{Quotation| | ||
| + | FDA plans to kill 50,000 Americans over the next month - over 16X the direct casualties from 2001/9/11 - by keeping it illegal for doctors to prescribe Paxlovid. Can no one stop these homicidal supervillains?}} | ||
| + | |||
| + | ---- | ||
| + | ==Ivermectin== | ||
| + | *[https://sebastianrushworth.com/2021/05/09/update-on-ivermectin-for-covid-19/ "Update on ivermectin for covid-19,"] Sebastian Rushworth (April 2021). | ||
<blockquote style="color:gray"> | <blockquote style="color:gray"> | ||
There is one thing that is rather odd with this study, and that is that the study authors were receiving payments from Sanofi-Pasteur, Glaxo-Smith-Kline, Janssen, Merck, and Gilead while conducting the study. Gilead makes remdesivir. Merck is developing two expensive new drugs to treat covid-19. Janssen, Glaxo-Smith-Kline, and Sanofi-Pasteur are all developers of covid vaccines. In other words, the authors of the study were receiving funding from companies that own drugs that are direct competitors to ivermectin. One might call this a conflict of interest, and wonder whether the goal of the study was to show a lack of benefit. It’s definitely a little bit suspicious... | There is one thing that is rather odd with this study, and that is that the study authors were receiving payments from Sanofi-Pasteur, Glaxo-Smith-Kline, Janssen, Merck, and Gilead while conducting the study. Gilead makes remdesivir. Merck is developing two expensive new drugs to treat covid-19. Janssen, Glaxo-Smith-Kline, and Sanofi-Pasteur are all developers of covid vaccines. In other words, the authors of the study were receiving funding from companies that own drugs that are direct competitors to ivermectin. One might call this a conflict of interest, and wonder whether the goal of the study was to show a lack of benefit. It’s definitely a little bit suspicious... | ||
Revision as of 10:46, 23 November 2021
General
- "A Guide to Home-Based Covid Treatment," from a reputable source, a pdf book.
FDA Murders
- Eliezer Yudkowsky tweet, November 2021. He also cites a good Astralcodex10 post on the situation.
FDA plans to kill 50,000 Americans over the next month - over 16X the direct casualties from 2001/9/11 - by keeping it illegal for doctors to prescribe Paxlovid. Can no one stop these homicidal supervillains?
Ivermectin
- "Update on ivermectin for covid-19," Sebastian Rushworth (April 2021).
There is one thing that is rather odd with this study, and that is that the study authors were receiving payments from Sanofi-Pasteur, Glaxo-Smith-Kline, Janssen, Merck, and Gilead while conducting the study. Gilead makes remdesivir. Merck is developing two expensive new drugs to treat covid-19. Janssen, Glaxo-Smith-Kline, and Sanofi-Pasteur are all developers of covid vaccines. In other words, the authors of the study were receiving funding from companies that own drugs that are direct competitors to ivermectin. One might call this a conflict of interest, and wonder whether the goal of the study was to show a lack of benefit. It’s definitely a little bit suspicious...
Tthis study is yet another one of those many studies that will not be able to show a meaningful effect on hard end points like hospitalization and death. It is a bit strange that studies keep being done on young healthy people who are at virtually zero risk from covid-19, rather than on the multi-morbid elderly, who are the ones we actually need an effective treatment for.
